| Lonza Group AG | 549.40 / +2.12% |
| Date/Time | 04/09 / 17:19 |
| Chg. / Chg.(%) | 11.40 / +2.12% |
| Bid | 549.20 / 10 |
| Ask | 553.00 / 9 |
| Open | 542.60 |
| Previous Close | 538.00 |
| High | 554.60 |
| Low | 542.60 |
| Volume [CHF] | 17,143,168.10 |
| Volume [Units] | 31,162 |
| Price fixings | 3131 |
| ISIN | CH0013841017 |
| Security | LONN/Z |
| Exchange | Cboe Europe CXE |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 495.100 |  |
|
| SIX Swiss Ex.. | 548.40 |  |
267,709 |
| London Inter.. | 548.32 | |
68,741 |
| Cboe Europe .. | 549.40 | |
31,162 |
| Cboe Europe .. | 548.40 | |
20,440 |
| Turquoise | 550.00 | |
20,417 |
| Nasdaq Other.. | 597.9900 | |
313 |
| Mexico | 12,477.46 |  |
340 |
| TradeGate | 294.000 | 298 | |
| Frankfurt | 293.9000 | 63 | |
| Düsseldorf | 291.20 | 0 | |
| München | 291.30 | 0 | |
| Berlin | 296.90 | 0 | |
| Hamburg | 291.30 | 0 | |
| gettex | 296.100 | ||
| Singapore | 79.97 | 500 | |
| EUREX | Options | ||
News
- Altimmune Expands AdCOVID™ Manufacturing Collaboration with Lonza
03/12/2021 / 07:00 - GlobeNewswire - Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy and Other Indications
01/12/2021 / 15:05 - GlobeNewswire - Achilles Therapeutics Appoints Arjan Roozen as VP, Site Head and General Manager
01/08/2021 / 13:00 - GlobeNewswire - Arbor Biotechnologies and Lonza Enter into Gene Editing Technology Licensing Deal
12/23/2020 / 14:00 - GlobeNewswire - Altimmune Adds Lonza as a Manufacturing Partner for Supply of AdCOVID™ its Single-Dose Intranasal Vaccine Candidate for COVID-19
11/10/2020 / 07:00 - GlobeNewswire
Real-time